Study
Nutritional Supplement Reduces Mortality in Malnourished Seniors
A high-protein nutritional supplement significantly reduced 90-day mortality rates in malnourished older adults after hospital discharge.
Summary
In plain language
Researchers found that a special high-protein nutritional supplement can reduce the risk of death in malnourished seniors after hospital discharge. In a study involving older adults hospitalized for heart failure or lung conditions, those who took the supplement had a lower 90-day mortality rate (4.8%) compared to those who received a placebo (9.7%). The supplement also helped improve nutritional status and weight gain. This study suggests that including such supplements in the diet of malnourished seniors could be beneficial, particularly after a hospital stay.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study was conducted to see if a high-protein oral nutritional supplement could help malnourished older adults recover after hospitalization. It was a rigorous trial involving 652 participants who were randomly assigned to receive either the supplement or a placebo. The study found that those taking the supplement had a significantly lower chance of dying within 90 days after discharge, and they showed improvements in nutritional status and body weight.
The study used a double-blind, placebo-controlled design to ensure reliable results.
Key findings included a reduction in 90-day mortality (4.8% vs. 9.7% for placebo) and better nutritional outcomes.
It's important to consider that the study focused on a specific group of hospitalized patients, which may limit its generalizability.
Seniors considering nutritional supplements should discuss these findings with their healthcare providers to determine the best course of action for their health needs.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Nutritional Supplement Reduces Mortality in Malnourished Seniors
Published October 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored October 22, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study scored highly in design, bias control, and statistical integrity due to its rigorous RCT methodology and comprehensive reporting. However, significant conflicts of interest due to industry funding and employment by Abbott Nutrition lowered the conflicts score. The study's relevance to the target population was high, but the lack of journal information affected the journal quality score.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 10.0/10 | |
| Bias control | 10.0/10 | |
| Statistical methods | 10.0/10 | |
| Reporting completeness | 10.0/10 | |
| Conflicts & funding | 5.0/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 10.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
The study evaluates the effects of a high-protein oral nutritional supplement on postdischarge outcomes in malnourished, hospitalized older adults. It found that the supplement reduced 90-day mortality but did not affect readmission rates.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Heart Disease
Heart disease, also known as cardiovascular disease, is a broad term that encompasses a range of conditions affecting the heart and blood vessels. It is a leading cause of death worldwide, particularly among older adults.
Atrial Fibrillation
Atrial fibrillation, often called AFib, is a common heart condition that causes an irregular and often rapid heart rate. It primarily affects older adults, leading to symptoms like fatigue and shortness of breath. Managing AFib is crucial to reduce the risk of stroke and improve quality of life.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.